411 related articles for article (PubMed ID: 20167145)
1. Efficacy and safety of budesonide/formoterol pressurized metered-dose inhaler: randomized controlled trial comparing once- and twice-daily dosing in patients with asthma.
Berger WE; Bleecker ER; O'Dowd L; Miller CJ; Mezzanotte W
Allergy Asthma Proc; 2010; 31(1):49-59. PubMed ID: 20167145
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and tolerability of once-daily budesonide/formoterol pressurized metered-dose inhaler in adults and adolescents with asthma previously stable with twice-daily budesonide/ formoterol dosing.
Kerwin EM; Oppenheimer JJ; LaForce C; Parasuraman B; Miller CJ; O'Dowd L; Goldman M
Ann Allergy Asthma Immunol; 2009 Jul; 103(1):62-72. PubMed ID: 19663129
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of budesonide/formoterol pressurized metered-dose inhaler versus budesonide pressurized metered-dose inhaler alone in Hispanic adults and adolescents with asthma: a randomized, controlled trial.
Zangrilli J; Mansfield LE; Uryniak T; O'Brien CD
Ann Allergy Asthma Immunol; 2011 Sep; 107(3):258-65.e2. PubMed ID: 21875546
[TBL] [Abstract][Full Text] [Related]
4. Once- vs twice-daily budesonide/formoterol in 6- to 15-year-old patients with stable asthma.
Eid NS; Noonan MJ; Chipps B; Parasuraman B; Miller CJ; O'Brien CD
Pediatrics; 2010 Sep; 126(3):e565-75. PubMed ID: 20713475
[TBL] [Abstract][Full Text] [Related]
5. Twelve-week, randomized, placebo-controlled, multicenter study of the efficacy and tolerability of budesonide and formoterol in one metered-dose inhaler compared with budesonide alone and formoterol alone in adolescents and adults with asthma.
Corren J; Korenblat PE; Miller CJ; O'Brien CD; Mezzanotte WS
Clin Ther; 2007 May; 29(5):823-843. PubMed ID: 17697902
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of budesonide and formoterol in one pressurised metered-dose inhaler in adults and adolescents with moderate to severe asthma: a randomised clinical trial.
Noonan M; Rosenwasser LJ; Martin P; O'Brien CD; O'Dowd L
Drugs; 2006; 66(17):2235-54. PubMed ID: 17137405
[TBL] [Abstract][Full Text] [Related]
7. Bronchodilator effect of single-dose formoterol administered by pressurized metered-dose inhaler in children with asthma aged 6 to <12 years receiving budesonide.
Berger WE; Gillen M; Eckerwall G; Uryniak T; Trudo FJ; Lampl KL
Allergy Asthma Proc; 2014; 35(2):134-40. PubMed ID: 24717790
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic equivalence of budesonide/formoterol delivered via breath-actuated inhaler vs pMDI.
Murphy KR; Dhand R; Trudo F; Uryniak T; Aggarwal A; Eckerwall G
Respir Med; 2015 Feb; 109(2):170-9. PubMed ID: 25596138
[TBL] [Abstract][Full Text] [Related]
9. The effect of budesonide/formoterol pressurized metered-dose inhaler on predefined criteria for worsening asthma in four different patient populations with asthma.
Murphy KR; Uryniak T; Martin UJ; Zangrilli J
Drugs R D; 2012 Mar; 12(1):9-14. PubMed ID: 22329608
[TBL] [Abstract][Full Text] [Related]
10. Budesonide/formoterol pressurized metered-dose inhaler versus budesonide: a randomized controlled trial in black patients with asthma.
Spector SL; Martin UJ; Uryniak T; O'Brien CD
J Asthma; 2012 Feb; 49(1):70-7. PubMed ID: 22133208
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of budesonide and formoterol in one pressurized metered-dose inhaler in patients with moderate to very severe chronic obstructive pulmonary disease: results of a 6-month randomized clinical trial.
Tashkin DP; Rennard SI; Martin P; Ramachandran S; Martin UJ; Silkoff PE; Goldman M
Drugs; 2008; 68(14):1975-2000. PubMed ID: 18778120
[TBL] [Abstract][Full Text] [Related]
12. The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma.
FitzGerald JM; Boulet LP; Follows RM
Clin Ther; 2005 Apr; 27(4):393-406. PubMed ID: 15922813
[TBL] [Abstract][Full Text] [Related]
13. Once-daily dosing with budesonide/formoterol compared with twice-daily budesonide/formoterol and once-daily budesonide in adults with mild to moderate asthma.
Kuna P; Creemers JP; Vondra V; Black PN; Lindqvist A; Nihlen U; Vogelmeier C
Respir Med; 2006 Dec; 100(12):2151-9. PubMed ID: 16701989
[TBL] [Abstract][Full Text] [Related]
14. The effect of budesonide and formoterol in one pressurized metered-dose inhaler on patient-reported outcomes in adults with mild-to-moderate persistent asthma.
Murphy K; Nelson H; Parasuraman B; Boggs R; Miller C; O'Dowd L
Curr Med Res Opin; 2008 Mar; 24(3):879-94. PubMed ID: 18267051
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of budesonide/formoterol pMDI vs budesonide pMDI in asthmatic children (6-<12 years).
Pearlman DS; Eckerwall G; McLaren J; Lamarca R; Puu M; Gilbert I; Jorup C; Sandin K; Lanz MJ
Ann Allergy Asthma Immunol; 2017 Apr; 118(4):489-499.e1. PubMed ID: 28256307
[TBL] [Abstract][Full Text] [Related]
16. Treatment of persistent asthma with Symbicort (budesonide/formoterol inhalation aerosol): an inhaled corticosteroid and long-acting beta2-adrenergic agonist in one pressurized metered-dose inhaler.
Berger WE; Noonan MJ
J Asthma; 2010 May; 47(4):447-59. PubMed ID: 20528601
[TBL] [Abstract][Full Text] [Related]
17. Long-term safety and asthma control measures with a budesonide/formoterol pressurized metered-dose inhaler in African American asthmatic patients: a randomized controlled trial.
Brown RW; O'Brien CD; Martin UJ; Uryniak T; Lampl KL
J Allergy Clin Immunol; 2012 Aug; 130(2):362-7.e9. PubMed ID: 22541245
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of budesonide/formoterol in one hydrofluoroalkane pressurized metered-dose inhaler in patients with chronic obstructive pulmonary disease: results from a 1-year randomized controlled clinical trial.
Rennard SI; Tashkin DP; McElhattan J; Goldman M; Ramachandran S; Martin UJ; Silkoff PE
Drugs; 2009; 69(5):549-65. PubMed ID: 19368417
[TBL] [Abstract][Full Text] [Related]
19. Long-term safety and asthma control with budesonide/formoterol versus budesonide pressurized metered-dose inhaler in asthma patients.
Peters SP; Prenner BM; Mezzanotte WS; Martin P; O'Brien CD
Allergy Asthma Proc; 2008; 29(5):499-516. PubMed ID: 18694544
[TBL] [Abstract][Full Text] [Related]
20. The functionality of a budesonide/formoterol pressurized metered-dose inhaler with an integrated actuation counter.
Shah S; White M; Uryniak T; O'Brien CD
Allergy Asthma Proc; 2010; 31(1):40-8. PubMed ID: 20167144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
